Medical/Pharmaceuticals

Formosa Pharmaceuticals and AimMax Therapeutics Announce the NDA Submission to the US FDA for APP13007 for the Treatment of Post-Operative Inflammation and Pain following Ocular Surgery

TAIPEI, May 4, 2023 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (6838.TWO) and AimMax Therapeutics, Inc. (United States) announce the submission of a New Drug Application to the United States Food & Drug Administration (US FDA) for APP13007, a novel aqueous nanosuspension formulation of the pot...

2023-05-05 08:00 2010

Recall Notice - SD Biosensor, Inc. requests discontinuation of use and disposal of specific Pilot™ COVID-19 At-Home Tests in the United States due to microbial contamination in the liquid buffer solution

SEOUL, South Korea, May 4, 2023 /PRNewswire/ -- SD Biosensor, Inc. today is requesting that consumers stop using and dispose of specific Pilot COVID-19 At-Home Tests inthe United States because potentially harmful bacteria were found in the tube with liquid inside (pouch 2 of the kits). The affe...

2023-05-05 04:00 2248

ABM Announces First Patient Dosed in Phase I Clinical Trial of MEK Inhibitor for Solid Tumor

SAN DIEGO and SHANGHAI, May 4, 2023 /PRNewswire/ -- ABM Therapeutics, an innovative clinical-stage biopharmaceutical company, with an emphasis on developing drugs with high blood–brain barrier (BBB) penetration for CNS diseases including brain metastases, today announced that the first patient wa...

2023-05-05 01:00 2553

SNIPR Biome's data on first clinical drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology

* SNIPR001 is a novel CRISPR-Cas therapeutic designed to selectively target antibiotic resistantE. coli, which can cause fatal infections in vulnerable hematological cancer patients             * SNIPR001 represents the first CRISPR- therapeutic developed to specifically removeE. coli in the ...

2023-05-05 00:52 2674

DetectedX's Radiology Online Learning Centre Passes 4,500 Users

DetectedX will Showcase New Interactive Educational Technology at SBI NATIONAL HARBOR, Md., May 4, 2023 /PRNewswire/ -- DetectedX, the leaders in intelligent interactive educational technology, announced today that it has surpassed 4,500 users of its Radiology Online Learning Centre. Users, whic...

2023-05-04 23:25 2282

National Comprehensive Cancer Network Honors Cancer Leaders who Guide the Future of Care

Theresa J. Franco, Fred & Pamela Buffett Cancer Center; F. Marc Stewart, City of Hope National Medical Center;Douglas E. Wood, UW Medicine Fred Hutchinson Cancer Center; andDonna Powell, NCCN, presented with awards during NCCN 2023 Annual Conference. PLYMOUTH MEETING, Pa., May 4, 2023 /PRNewswir...

2023-05-04 23:00 2680

ANGUS ANNOUNCES CORPORATE REBRANDING, WILL CHANGE NAME TO "ADVANCION"

New name and brand reflect Company's strategic transformation into a leading global producer of specialty ingredients for Life Sciences, Personal Care and other essential markets BUFFALO GROVE, Ill., May 4, 2023 /PRNewswire/ -- ANGUS Chemical Company ("ANGUS" or "Company") today unveiled a new n...

2023-05-04 21:00 3637

Cambridge Infinitus Research Centre Launches World Leading AI-based Technology Platform ERnet for Studies of Cellular Health

GUANGZHOU, China, May 4, 2023 /PRNewswire/ -- The Cambridge Infinitus Research Centre (CIRCE) was officially established in 2015 as Infinitus' first international scientific research collaboration platform outside ofChina. CIRCE recently achieved another scientific and technological breakthrough ...

2023-05-04 16:00 2923

First Subject Enrolled in Boan Biotech's International Multi-Center Phase 3 Clinical Study for Its Denosumab BA6101 & BA1102

YANTAI, China, May 4, 2023 /PRNewswire/ -- Boan Biotech today announced that an international multi-center Phase 3 clinical study for its in-house developed Denosumab Injection (BA6101; BA1102) has been initiated inEurope, the United States, and Japan, and recently the first patient in (FPI) was ...

2023-05-04 14:40 4084

Hasten Biopharma Acquires Commercial Rights in China for Roche's Antibiotic Rocephin®

The acquisition will deliver strong commercial synergy with Hasten's current critical care portfolio SHANGHAI, May 4, 2023 /PRNewswire/ -- Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has acquired the commercial rights inChina for Rocephin®, a long-acting, broad spe...

2023-05-04 14:00 2143

European Wellness Joint Research with Heidelberg University in Journal Publication

HEIDELBERG, Germany, May 4, 2023 /PRNewswire/ -- European Wellness Academy (EWA), a wholly owned subsidiary European Wellness Biomedical Group (EW Group) has entered into a cooperation agreement with Heidelberg University in medical research. The research project, titled "A Tendon Specific Double...

2023-05-04 13:39 2420

George Clinical Applauded by Frost & Sullivan for Its Competitive Differentiation and Leadership in Strategy Execution in the Asia Pacific region

George Clinical cares for its employees, enables business continuity, and builds on its expertise, giving it a competitive industry advantage. SAN ANTONIO, May 4, 2023 /PRNewswire/ -- Frost & Sullivan studied the contract research organization industry and, based on its findings, recognizes Georg...

2023-05-04 11:00 2038

Annalise.ai grows global footprint with expansion into India

Leading global AI radiology company opens new office in Chennai CHENNAI, India, May 4, 2023 /PRNewswire/ -- Annalise.ai, one of the world's largest artificial intelligence (AI) radiology companies, has today announced it is continuing its global expansion with the opening of the Annalise India ...

2023-05-04 10:56 2642

Full-Life Technologies Announces Land Purchase in Belgium to Establish GMP Manufacturing Facility for Radiopharmaceutical Drug Production

GEMBLOUX, Belgium, May 3, 2023 /PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today is pleased to announce that it has closed on an important land purchase in Wallonia,Belgium, and signed a purchase agreement to build a state-of-the-art, ...

2023-05-04 10:00 1900

Alma Lasers' Global Expansion and Vision for Holistic Wellness Solutions Unveiled at Fifth 'Alma Academy' in Italy, Attended by Physicians from 46 Countries

CAESAREA, Israel, May 4, 2023 /PRNewswire/ -- Alma Lasers , a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, is excited to announce the successful opening of the fifth Alma Academy. Nearly 500 physicians from 46 countries ...

2023-05-04 07:22 2686

Formus Labs, Pioneering Developer of AI-Powered 3D Orthopedic Surgery Planning Technology, Receives FDA Clearance

Formus combines AI and biomechanics to empower orthopedic surgeons with fully interactive 3D surgical plans that optimize the preoperative (pre-op) planning process WARSAW, Ind., May 4, 2023 /PRNewswire/ -- Formus Labs today announced it has received 510(k) clearance from the United States Food ...

2023-05-04 06:18 2200

Aktiia's Continual Blood Pressure Solution Shows Comparable Results to ABPM

NEUCHÂTEL, Switzerland, May 4, 2023 /PRNewswire/ -- Aktiia, a health tech startup transforming hypertension care, has announced promising results from a preliminary study comparing their cuff-less and continual blood pressure monitor with traditional ambulatory blood pressure monitors (ABPM). The...

2023-05-04 00:00 2415

SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector

ZUG, Switerland, May 3, 2023 /PRNewswire/ -- SHL Medical, a world-leading provider of advanced drug delivery solutions, announced that it has signed a collaboration agreement with MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for infl...

2023-05-03 22:43 3248

EDAN Announces Integration with PointClickCare for Better Senior Primary Care

SAN DIEGO, May 3, 2023 /PRNewswire/ -- Edan Instruments, Inc. (300206.SZ), a leading healthcare company and medical devices manufacturer, recently announced its integration with PointClickCare through its newly launched informatics solutions Allink. The solution ...

2023-05-03 21:56 2759

Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic™ Clinical Trial

BELTSVILLE, Md., May 3, 2023 /PRNewswire/ -- Reprocell USA, a CRO, has been awarded a contract to provide support for Lantern Pharma's Phase 2 clinical trial entitled "A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers with Advanced Lung Adenocarcinoma (HARMONIC)". The Harmonic™ s...

2023-05-03 21:00 2191
1 ... 202203204205206207208 ... 614